Skip to content

Study on the effect of oral satavar and vaginal pessary of camphor and Rogan e gul in the management of vaginal dryness: A pilot study

A pilot study on the efficacy of oral satavar and vaginal pessary of camphor and Rogan e gul in the management of Vaginal dryness - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/10/096359
Enrollment
10
Registered
2025-10-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N952- Postmenopausal atrophic vaginitis

Interventions

Intervention1: 1.oral satavar 2. Vaginal pessary of Rogan e gul and camphor: 1. Patient will be given 6gm of above mentioned drug powder per day for 90 days 2. Patient will be given vaginal pessary

Sponsors

Government nizamia tibbi college
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Presence of at least one symptoms such as itching burning discomfort or pain during intercourse for at least past 3 months 2. Menopausal status: a.postmenopausal woman (greater than 12 months since last menstrual period) 3.no use systemic or local estrogen therapy hormonal contraceptive or vaginal lubricant for at least 2 weeks prior to study initiation

Exclusion criteria

Exclusion criteria: 1. Presence of vaginal or urinary tract infection 2.pelvic organ prolapse, severe vaginal atrophy with ulceration 3.use of systemic estrogen 4.use of vaginal lubricant

Design outcomes

Primary

MeasureTime frame
1.change in vaginal dryness severity from baseline to end of treatment measured using Vas score or vaginal dryness self assessment scaleTimepoint: 90 days

Secondary

MeasureTime frame
Associated symptoms improvement ( reduction in itching, burning)Timepoint: 90 days

Countries

India

Contacts

Public ContactDr Amreen Begum

Government nizamia tibbi college and general hospital

syedaabudunnisa@gmail.com9492027082

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026